ATE437678T1 - Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand) - Google Patents

Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)

Info

Publication number
ATE437678T1
ATE437678T1 AT02735595T AT02735595T ATE437678T1 AT E437678 T1 ATE437678 T1 AT E437678T1 AT 02735595 T AT02735595 T AT 02735595T AT 02735595 T AT02735595 T AT 02735595T AT E437678 T1 ATE437678 T1 AT E437678T1
Authority
AT
Austria
Prior art keywords
sulfamat
oestrone
trail
tnf
compositions
Prior art date
Application number
AT02735595T
Other languages
English (en)
Inventor
Graham Keith Packham
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE437678T1 publication Critical patent/ATE437678T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT02735595T 2001-06-07 2002-06-06 Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand) ATE437678T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113920.3A GB0113920D0 (en) 2001-06-07 2001-06-07 Composition
PCT/GB2002/002541 WO2002098511A1 (en) 2001-06-07 2002-06-06 Compositions comprising oestrone-3-0-sulphamate and trail (tnf-related apoptosis inducing ligand)

Publications (1)

Publication Number Publication Date
ATE437678T1 true ATE437678T1 (de) 2009-08-15

Family

ID=9916140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735595T ATE437678T1 (de) 2001-06-07 2002-06-06 Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)

Country Status (8)

Country Link
US (1) US7211246B2 (de)
EP (1) EP1399221B1 (de)
JP (1) JP4376055B2 (de)
AT (1) ATE437678T1 (de)
DE (1) DE60233136D1 (de)
ES (1) ES2330088T3 (de)
GB (1) GB0113920D0 (de)
WO (1) WO2002098511A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0702446D0 (en) * 2007-02-08 2007-03-21 Sterix Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
ATE503013T1 (de) * 1995-06-29 2011-04-15 Immunex Corp Cytokin welches apoptose induziert
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
ATE401896T1 (de) * 1998-06-10 2008-08-15 Sterix Ltd Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
JP5042411B2 (ja) * 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
ATE454395T1 (de) 2003-03-24 2010-01-15 Sterix Ltd Oestrogenderivate als steroid sulphatase inhibitoren

Also Published As

Publication number Publication date
ES2330088T3 (es) 2009-12-04
EP1399221A1 (de) 2004-03-24
JP2004537523A (ja) 2004-12-16
EP1399221B1 (de) 2009-07-29
DE60233136D1 (de) 2009-09-10
GB0113920D0 (en) 2001-08-01
US20040166090A1 (en) 2004-08-26
JP4376055B2 (ja) 2009-12-02
WO2002098511A1 (en) 2002-12-12
US7211246B2 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
EP1406632A4 (de) Substituierte 3-aryl-5-aryl- 1,2,4 -oxadiazole und analoga als aktivatoren von caspases und apoptose-induktoren und ihre verwendung
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
BR0216099B1 (pt) "conjunto de desgaste".
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
EP1476180A4 (de) Interleukin-2 mutanten mit verringerter toxizität
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
PT1193270E (pt) Pirrolobenzodiazepinas
TR199901877A3 (tr) Zararli eklem bacaklilarin imhasi için terkip.
DE60206684D1 (de) Zusammensetzungen mit der Eigenschaft der Dilatanz
NO20011190D0 (no) Keramiske karbonsammensetninger
IS2606B (is) Bindill tengdur æxlisdrepþætti
AU2002303694A1 (en) Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
ATE287403T1 (de) 6-phenylbenzonaphthyidine
DE60233136D1 (de) Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
SE0302361D0 (sv) Inhibering av upptagning av monoamin
EP1392294A4 (de) 7,8-kondensiertes 4$i(h)-chromen und analoga als caspase-aktivatoren und auslöser von apoptosis und ihre verewendung
PL365687A1 (en) Novel trioxepan compounds
DK1144348T3 (da) LTA4-hydrolaseinhibitorer
ATE253562T1 (de) Substituierte 2,4-diamino-1,3,5-triazine
AR034138A1 (es) Equipo filtrante
AU2002303746A1 (en) 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties